Suppr超能文献

纤溶酶对血管性血友病因子和血小板的影响:一项叙述性综述

Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review.

作者信息

van der Vorm Lisa N, Remijn Jasper A, de Laat Bas, Huskens Dana

机构信息

Synapse Research Institute, Maastricht, The Netherlands.

Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.

出版信息

TH Open. 2018 Jun 7;2(2):e218-e228. doi: 10.1055/s-0038-1660505. eCollection 2018 Apr.

Abstract

Plasmin is the major fibrinolytic protease responsible for dissolving thrombi by cleavage of its primary substrate fibrin. In addition, emerging evidence points to other roles of plasmin: (1) as a back-up for ADAMTS13 in proteolysis of ultra-large von Willebrand factor (VWF) multimers and (2) as an activator of platelets. Although the molecular mechanisms of fibrinolysis are well defined, insights on the effects of plasmin on VWF and platelets are relatively scarce and sometimes conflicting. Hence, this review provides an overview of the literature on the effects of plasmin on VWF multimeric structures, on VWF binding to platelets, and on platelet activation. This information is placed in the context of possible applications of thrombolytic therapy for the condition thrombotic thrombocytopenic purpura.

摘要

纤溶酶是主要的纤维蛋白溶解蛋白酶,负责通过裂解其主要底物纤维蛋白来溶解血栓。此外,越来越多的证据表明纤溶酶还有其他作用:(1)作为ADAMTS13的备用蛋白,参与超大血管性血友病因子(VWF)多聚体的蛋白水解;(2)作为血小板的激活剂。尽管纤维蛋白溶解的分子机制已得到明确,但关于纤溶酶对VWF和血小板作用的见解相对较少,且有时相互矛盾。因此,本综述概述了有关纤溶酶对VWF多聚体结构、VWF与血小板结合以及血小板激活作用的文献。这些信息与溶栓疗法在血栓性血小板减少性紫癜中的可能应用相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a0c/6524877/f5500b0b9316/10-1055-s-0038-1660505-i180014-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验